跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maytansine
首页
药物
Maytansine
Maytansine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for preparing maytansine conjugate and application of maytansine conjugate
申请人: SHENZHEN TAIERKANG BIOMEDICAL TECH CO LTD
优先权: 2023
CN
Maytansines and maytansine conjugates
申请人: SANTI DANIEL
优先权: 2002
US
Maytansine nanoparticle composition connected with trastuzumab
申请人: UNIV YANTAI
优先权: 2020
CN
Maytansine nanoparticle composition connected with trastuzumab fragment
申请人: UNIV YANTAI
优先权: 2020
CN
Preparation method of maytansine ester and intermediate thereof
申请人: KAIHUI SCIENCE & TECH DEVELOPMENT SHANGHAI CO LTD
优先权: 2016
CN
MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME
申请人: ANGIEX INC
优先权: 2021
CN
EP
US
WO
4 件公开
Related maytansine derivatives and preparation method and application thereof
申请人: BIO THERA SOLUTIONS LTD
优先权: 2012
CN
2 件公开
Compound, preparation method thereof, and preparation method of maytansine DM1
申请人: NANJING LEVENA BIOPHARMA CO LTD
优先权: 2014
CN
药物
反馈